Cdk1/Cyclin B1 controls fas-mediated apoptosis by regulating caspase-8 activity

Molecular and Cellular Biology

Volumn 30, Issue 24, 2010, Pages 5726-5740

  Matthess, Yves ^a   Raab, Monika ^a   Sanhaji, Mourad ^a   Lavrik, Inna N ^b   Strebhardt, Klaus ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CASPASE 8; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYSTEINE PROTEINASE INHIBITOR; FAS ANTIGEN; HYBRID PROTEIN; LEUPEPTIN;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL LINE; FEMALE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; CASPASE 8; CDC2 PROTEIN KINASE; CELL LINE; CYCLIN B1; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; LEUPEPTINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 79960297569     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00731-10     Document Type: Article

References (50)

1. Allan, L. A., and P. R. Clarke. 2007. Phosphorylation of caspase-9 by CDK1/ cyclin B1 protects mitotic cells against apoptosis. Mol. Cell 26:301-310.
2. Andersen, J. L., C. E. Johnson, C. D. Freel, A. B. Parrish, J. L. Day, M. R. Buchakjian, L. K. Nutt, J. W. Thompson, M. A. Moseley, and S. Kornbluth. 2009. Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2. EMBO J. 28:3216-3227.
3. Bentley, A. M., G. Normand, J. Hoyt, and R. W. King. 2007. Distinct sequence elements of cyclin B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis. Mol. Biol. Cell 18:4847-4858.
4. Blangy, A., H. A. Lane, P. d'Herin, M. Harper, M. Kress, and E. A. Nigg. 1995. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83:1159-1169.
5. Chang, D. W., Z. Xing, V. L. Capacio, M. E. Peter, and X. Yang. 2003. Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22: 4132-4142.
6. Cox, A., A. M. Dunning, M. Garcia-Closas, S. Balasubramanian, M. W. Reed, K. A. Pooley, S. Scollen, C. Baynes, B. A. Ponder, S. Chanock, J. Lissowska, L. Brinton, B. Peplonska, M. C. Southey, J. L. Hopper, M. R. McCredie, G. G. Giles, O. Fletcher, N. Johnson, S. S. dos, I. L. Gibson, S. E. Bojesen, B. G. Nordestgaard, C. K. Axelsson, D. Torres, U. Hamann, C. Justenhoven, H. Brauch, J. Chang-Claude, S. Kropp, A. Risch, S. Wang- Gohrke, P. Schurmann, N. Bogdanova, T. Dork, R. Fagerholm, K. Aaltonen, C. Blomqvist, H. Nevanlinna, S. Seal, A. Renwick, M. R. Stratton, N. Rahman, S. Sangrajrang, D. Hughes, F. Odefrey, P. Brennan, A. B. Spurdle, G. Chenevix-Trench, J. Beesley, A. Mannermaa, J. Hartikainen, V. Kataja, V. M. Kosma, F. J. Couch, J. E. Olson, E. L. Goode, A. Broeks, M. K. Schmidt, F. B. Hogervorst, L. J. Van't Veer, D. Kang, K. Y. Yoo, D. Y. Noh, S. H. Ahn, S. Wedren, P. Hall, Y. L. Low, J. Liu, R. L. Milne, G. Ribas, A. Gonzalez-Neira, J. Benitez, A. J. Sigurdson, D. L. Stredrick, B. H. Alexander, J. P. Struewing, P. D. Pharoah, and D. F. Easton. 2007. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39:352-358.
7. Cursi, S., A. Rufini, V. Stagni, I. Condo, V. Matafora, A. Bachi, A. P. Bonifazi, L. Coppola, G. Superti-Furga, R. Testi, and D. Barila. 2006. Src kinase phosphorylates caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J. 25:1895-1905.
8. Degterev, A., and J. Yuan. 2008. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell. Biol. 9:378-390.
9. Fulda, S. 2009. Caspase-8 in cancer biology and therapy. Cancer Lett. 281: 128-133.
10. Fulda, S., M. U. Kufer, E. Meyer, V. F. van, B. Dockhorn-Dworniczak, and K. M. Debatin. 2001. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20:5865-5877.
11. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
12. Harada, K., S. Toyooka, N. Shivapurkar, A. Maitra, J. L. Reddy, H. Matta, K. Miyajima, C. F. Timmons, G. E. Tomlinson, D. Mastrangelo, R. J. Hay, P. M. Chaudhary, and A. F. Gazdar. 2002. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res. 62:5897-5901.
13. Holtrich, U., G. Wolf, A. Brauninger, T. Karn, B. Bohme, H. Rubsamen- Waigmann, and K. Strebhardt. 1994. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc. Natl. Acad. Sci. U. S. A. 91:1736-1740.
14. Hughes, M. A., N. Harper, M. Butterworth, K. Cain, G. M. Cohen, and M. MacFarlane. 2009. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol. Cell 35:265-279.
15. Igney, F. H., and P. H. Krammer. 2002. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2:277-288.
16. Jackman, M., C. Lindon, E. A. Nigg, and J. Pines. 2003. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5:143- 148.
17. Jiang, M., K. Zhu, J. Grenet, and J. M. Lahti. 2008. Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells. Biochim. Biophys. Acta 1783:1055-1067.
18. Kappel, S., Y. Matthess, M. Kaufmann, and K. Strebhardt. 2007. Silencing of mammalian genes by tetracycline-inducible shRNA expression. Nat. Protoc. 2:3257-3269.
19. Kappel, S., Y. Matthess, B. Zimmer, M. Kaufmann, and K. Strebhardt. 2006. Tumor inhibition by genomically integrated inducible RNAi-cassettes. Nucleic Acids Res. 34:4527-4536.
20. Keen, N., and S. Taylor. 2004. Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4:927-936.
21. Kimura, K., O. Cuvier, and T. Hirano. 2001. Chromosome condensation by a human condensin complex in Xenopus egg extracts. J. Biol. Chem. 276: 5417-5420.
22. Lavrik, I., A. Krueger, I. Schmitz, S. Baumann, H. Weyd, P. H. Krammer, and S. Kirchhoff. 2003. The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell Death. Differ. 10:144-145.
23. Malumbres, M., and M. Barbacid. 2001. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1:222-231.
24. Malumbres, M., and M. Barbacid. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9:153-166.
25. Mashal, R. D., S. Lester, C. Corless, J. P. Richie, R. Chandra, K. J. Propert, and A. Dutta. 1996. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res. 56:4159-4163.
26. Matthess, Y., S. Kappel, B. Spankuch, B. Zimmer, M. Kaufmann, and K. Strebhardt. 2005. Conditional inhibition of cancer cell proliferation by tetracycline- responsive, H1 promoter-driven silencing of PLK1. Oncogene 24: 2973-2980.
27. Medema, J. P., C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann, P. H. Krammer, and M. E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-2804.
28. Muzio, M., B. R. Stockwell, H. R. Stennicke, G. S. Salvesen, and V. M. Dixit. 1998. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:2926-2930.
29. Nigg, E. A. 2001. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell. Biol. 2:21-32.
30. Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature 344:503-508.
31. Peter, M., J. Nakagawa, M. Doree, J. C. Labbe, and E. A. Nigg. 1990. In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase. Cell 61:591-602.
32. Pines, J. 2006. Mitosis: a matter of getting rid of the right protein at the right time. Trends Cell Biol. 16:55-63.
33. Raab, M., S. Pfister, and C. E. Rudd. 2001. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15:921-933.
34. Raab, M., M. Yamamoto, and C. E. Rudd. 1994. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck. Mol. Cell. Biol. 14:2862-2870.
35. Reindl, W., J. Yuan, A. Kramer, K. Strebhardt, and T. Berg. 2008. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions. Chem. Biol. 15:459-466.
36. Rudner, A. D., and A. W. Murray. 2000. Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase-promoting complex. J. Cell Biol. 149:1377-1390.
37. Scaffidi, C., I. Schmitz, P. H. Krammer, and M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541- 1548.
38. Senft, J., B. Helfer, and S. M. Frisch. 2007. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res. 67:11505-11509.
39. Shapiro, G. I. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24:1770-1783.
40. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, G. Litwack, and E. S. Alnemri. 1996. Molecular ordering of the Fas-apoptotic pathway: the Fas/ APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U. S. A. 93:14486- 14491.
41. Strebhardt, K. 2010. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 9:643-660.
42. Strebhardt, K., and A. Ullrich. 2006. Targeting polo-like kinase 1 for cancer therapy. Nat. Rev. Cancer 6:321-330.
43. Stupack, D. G., T. Teitz, M. D. Potter, D. Mikolon, P. J. Houghton, V. J. Kidd, J. M. Lahti, and D. A. Cheresh. 2006. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439:95-99.
44. Teitz, T., T. Wei, M. B. Valentine, E. F. Vanin, J. Grenet, V. A. Valentine, F. G. Behm, A. T. Look, J. M. Lahti, and V. J. Kidd. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6:529-535.
45. Vassilev, L. T., C. Tovar, S. Chen, D. Knezevic, X. Zhao, H. Sun, D. C. Heimbrook, and L. Chen. 2006. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. U. S. A. 103:10660-10665.
46. Winters, Z. E., N. C. Hunt, M. J. Bradburn, J. A. Royds, H. Turley, A. L. Harris, and C. J. Norbury. 2001. Subcellular localization of cyclin B, Cdc2, and p21WAF1/CIP1 in breast cancer. association with prognosis. Eur. J. Cancer 37:2405-2412.
47. Yang, X., M. S. Merchant, M. E. Romero, M. Tsokos, L. H. Wexler, U. Kontny, C. L. Mackall, and C. J. Thiele. 2003. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res. 63:1122-1129.
48. Yuan, J., A. Kramer, Y. Matthess, R. Yan, B. Spankuch, R. Gatje, R. Knecht, M. Kaufmann, and K. Strebhardt. 2006. Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene 25:1753-1762.
49. Yuan, J., R. Yan, A. Kramer, F. Eckerdt, M. Roller, M. Kaufmann, and K. Strebhardt. 2004. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 23:5843-5852.
50. Zhang, L., J. Yu, B. H. Park, K. W. Kinzler, and B. Vogelstein. 2000. Role of BAX in the apoptotic response to anticancer agents. Science 290:989-992.